Yuh-Jin Liang

6PUBLICATIONS
8CO-AUTHORS
Predictive and prognostic markersNanotoxicology, health and safetyEpigenetics (incl. genome methylation and epigenomics)Molecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 30, 2025
The impact of single-nucleotide variants of hepatitis B virus and antiviral on liver cancer in gray zone patients.

Wei Teng, Ting-Tsung Chang, Chien-Wei Su

|Dec 18, 2023
Antiviral therapy reduces hepatocellular carcinoma through suppressing hepatitis B virus replication may improve ER stress, mitochondrial and metabolic dysfunctions and decrease p62 in hybridized mice with single HBV transgene and miR-122.

Yuh-Jin Liang, Yu-Wei Chiou, Abby Pei-Ting Chiu

|Mar 10, 2022
Glycosphingolipids in human embryonic stem cells and breast cancer stem cells, and potential cancer therapy strategies based on their structures and functions.

Yuh-Jin Liang

|Feb 25, 2022
Upregulation of USP22 and ABCC1 during Sorafenib Treatment of Hepatocellular Carcinoma Contribute to Development of Resistance.

Yung-Sheng Chang, Chien-Wei Su, San-Chi Chen

|Mar 06, 2021
Clinical Implications of HBV PreS/S Mutations and the Effects of PreS2 Deletion on Mitochondria, Liver Fibrosis, and Cancer Development.

Yuh-Jin Liang, Wei Teng, Chih-Li Chen

|Oct 17, 2019
High Expression of MicroRNA-196a is Associated with Progression of Hepatocellular Carcinoma in Younger Patients.

Shen-Yung Wang, Chih-Li Chen, Yu-Chen Hu

Pageof 1

Frequent Collaborators

4 joint publications

Chien-Wei Su

2 joint publications

Jaw-Ching Wu

1 joint publications

Shen-Yung Wang

1 joint publications

Wen-Juei Jeng